These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Simultaneous inhibition of MarR by salicylate and efflux pumps by curcumin sensitizes colistin resistant clinical isolates of Enterobacteriaceae. Sundaramoorthy NS; Sivasubramanian A; Nagarajan S Microb Pathog; 2020 Nov; 148():104445. PubMed ID: 32814143 [TBL] [Abstract][Full Text] [Related]
3. Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor. Sundaramoorthy NS; Suresh P; Selva Ganesan S; GaneshPrasad A; Nagarajan S Sci Rep; 2019 Dec; 9(1):19845. PubMed ID: 31882661 [TBL] [Abstract][Full Text] [Related]
4. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [TBL] [Abstract][Full Text] [Related]
5. Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae. Brennan-Krohn T; Pironti A; Kirby JE Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061285 [TBL] [Abstract][Full Text] [Related]
6. Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant Jangra M; Kaur M; Tambat R; Rana R; Maurya SK; Khatri N; Ghafur A; Nandanwar H Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936101 [TBL] [Abstract][Full Text] [Related]
7. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance. Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand. Eiamphungporn W; Yainoy S; Jumderm C; Tan-Arsuwongkul R; Tiengrim S; Thamlikitkul V J Glob Antimicrob Resist; 2018 Dec; 15():32-35. PubMed ID: 29935331 [TBL] [Abstract][Full Text] [Related]
9. The first report of emerging mobilized colistin-resistance ( Moosavian M; Emam N Infect Drug Resist; 2019; 12():1001-1010. PubMed ID: 31118706 [No Abstract] [Full Text] [Related]
10. Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Hu Y; Liu Y; Coates A Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373798 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of EDTA- and DPA-Based Microdilution Phenotypic Tests for the Detection of MCR-Mediated Colistin Resistance in Enterobacteriaceae. Büdel T; Clément M; Bernasconi OJ; Principe L; Perreten V; Luzzaro F; Endimiani A Microb Drug Resist; 2019 May; 25(4):494-500. PubMed ID: 30431401 [TBL] [Abstract][Full Text] [Related]
12. Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints. Tsala M; Vourli S; Georgiou PC; Pournaras S; Tsakris A; Daikos GL; Mouton JW; Meletiadis J J Antimicrob Chemother; 2018 Apr; 73(4):953-961. PubMed ID: 29377998 [TBL] [Abstract][Full Text] [Related]
13. A simple phenotypic method for screening of MCR-1-mediated colistin resistance. Coppi M; Cannatelli A; Antonelli A; Baccani I; Di Pilato V; Sennati S; Giani T; Rossolini GM Clin Microbiol Infect; 2018 Feb; 24(2):201.e1-201.e3. PubMed ID: 28827120 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study. Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700 [TBL] [Abstract][Full Text] [Related]
16. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856 [TBL] [Abstract][Full Text] [Related]
17. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates. Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587 [TBL] [Abstract][Full Text] [Related]
19. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo. Sundaramoorthy NS; Mitra K; Ganesh JS; Makala H; Lotha R; Bhanuvalli SR; Ulaganathan V; Tiru V; Sivasubramanian A; Nagarajan S Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]